Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers

International Journal of Pharmaceutics

Volumn 337, Issue 1-2, 2007, Pages 254-264

  Borges, Olga ^a   Borchard, Gerrit ^b   de Sousa, Adriano ^a   Junginger, Hans E ^c   Cordeiro da Silva, Anabela ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c NARESUAN UNIVERSITY   (Thailand)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alginate; CD69 expression; Chitosan; CpG ODN; Lymphocyte activation

Indexed keywords

ALGINIC ACID; BIOPOLYMER; CD69 ANTIGEN; CHITOSAN; CONCANAVALIN A; CPG OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; UPREGULATION;

ALGINATES; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; BIOCOMPATIBLE MATERIALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHITOSAN; CONCANAVALIN A; DNA; DRUG CARRIERS; GLUCURONIC ACID; HEXURONIC ACIDS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MICE; MICE, INBRED BALB C; MITOGENS; SPLEEN; UP-REGULATION;

EID: 34248584919     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.021     Document Type: Article

References (39)

1. Babensee J.E., and Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J. Biomed. Mater. Res. A 74 (2005) 503-510
2. Baudner B.C., Verhoef J.C., Giuliani M.M., Peppoloni S., Rappuoli R., Del Giudice G., and Junginger H.E. Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform. J. Drug Target 13 (2005) 489-498
3. Bianco I.D., Balsinde J., Beltramo D.M., Castagna L.F., Landa C.A., and Dennis E.A. Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages. FEBS Lett. 466 (2000) 292-294
4. Borges O., Borchard G., Verhoef J.C., de Sousa A., and Junginger H.E. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int. J. Pharm. 299 (2005) 155-166
5. Borges O., Cordeiro-da-Silva A., Romeijn S.G., Amidi M., de Sousa A., Borchard G., and Junginger H.E. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J. Control Release 114 (2006) 348-358
6. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., and Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160 (1998) 870-876
7. Dodane V., Amin Khan M., and Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182 (1999) 21-32
8. Felt O., Buri P., and Gurny R. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24 (1998) 979-993
9. Feng C., Woodside K.J., Vance B.A., El-Khoury D., Canelles M., Lee J., Gress R., Fowlkes B.J., Shores E.W., and Love P.E. A potential role for CD69 in thymocyte emigration. Int. Immunol. 14 (2002) 535-544
10. Flo T.H., Ryan L., Latz E., Takeuchi O., Monks B.G., Lien E., Halaas O., Akira S., Skjak-Braek G., Golenbock D.T., and Espevik T. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 277 (2002) 35489-35495
11. George M., and Abraham T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-a review. J. Control Release 114 (2006) 1-14
12. Jork A., Thurmer F., Cramer H., Zimmermann G., Gessner P., Hamel K., Hofmann G., Kuttler B., Hahn H.J., Josimovic-Alasevic O., Fritsch K.G., and Zimmermann U. Biocompatible alginate from freshly collected Laminaria pallida for implantation. Appl. Microbiol. Biotechnol. 53 (2000) 224-229
13. Kim B., Bowersock T., Griebel P., Kidane A., Babiuk L.A., Sanchez M., Attah-Poku S., Kaushik R.S., and Mutwiri G.K. Mucosal immune responses following oral immunization with rotavirus antigens encapsulated in alginate microspheres. J. Control Release 85 (2002) 191-202
14. Klinman D.M. Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4 (2004) 249-258
15. Klock G., Pfeffermann A., Ryser C., Grohn P., Kuttler B., Hahn H.J., and Zimmermann U. Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18 (1997) 707-713
16. Kranzer K., Bauer M., Lipford G.B., Heeg K., Wagner H., and Lang R. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology 99 (2000) 170-178
17. Maeda Y., and Kimura Y. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J. Nutr. 134 (2004) 945-950
18. Matsunaga T., Yanagiguchi K., Yamada S., Ohara N., Ikeda T., and Hayashi Y. Chitosan monomer promotes tissue regeneration on dental pulp wounds. J. Biomed. Mater. Res. A 76 (2006) 711-720
19. Mebius R.E., and Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 5 (2005) 606-616
20. Morgan C.D., Greene Jr. J.F., and Measel Jr. J.W. Induction of surface antigen CD69 expression in T-lymphocytes following exposure to actinomycin D. Int. J. Immunopharmacol. 21 (1999) 689-703
21. Mori T., Murakami M., Okumura M., Kadosawa T., Uede T., and Fujinaga T. Mechanism of macrophage activation by chitin derivatives. J. Vet. Med. Sci. 67 (2005) 51-56
22. Nishimura K., Nishimura S., Seo H., Nishi N., Tokura S., and Azuma I. Effect of multiporous microspheres derived from chitin and partially deacetylated chitin on the activation of mouse peritoneal macrophages. Vaccine 5 (1987) 136-140
23. O'Hagan D. Microparticles as vaccine delivery systems. In: Schijins V., and O'Hagan D. (Eds). Immunopotentiators in Modern Vaccines vol. 1 (2006), Academic Press 123-147
24. Orive G., Carcaboso A.M., Hernandez R.M., Gascon A.R., and Pedraz J.L. Biocompatibility evaluation of different alginates and alginate-based microcapsules. Biomacromolecules 6 (2005) 927-931
25. Otterlei M., Sundan A., Skjak-Braek G., Ryan L., Smidsrod O., and Espevik T. Similar mechanisms of action of defined polysaccharides and lipopolysaccharides: characterization of binding and tumor necrosis factor alpha induction. Infect. Immun. 61 (1993) 1917-1925
26. Porporatto C., Bianco I.D., and Correa S.G. Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration. J. Leukoc. Biol. 78 (2005) 62-69
27. Read R.C., Naylor S.C., Potter C.W., Bond J., Jabbal-Gill I., Fisher A., Illum L., and Jennings R. Effective nasal influenza vaccine delivery using chitosan. Vaccine 23 (2005) 4367-4374
28. Reddy M., Eirikis E., Davis C., Davis H.M., and Prabhakar U. Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function. J. Immunol. Methods 293 (2004) 127-142
29. Sancho D., Gomez M., and Sanchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 26 (2005) 136-140
30. Seferian P.G., and Martinez M.L. Immune stimulating activity of two new chitosan containing adjuvant formulations. Vaccine 19 (2000) 661-668
31. Shibata Y., Foster L.A., Metzger W.J., and Myrvik Q.N. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-d-glucosamine, in mice. Infect. Immun. 65 (1997) 1734-1741
32. Suckow M.A., Jarvinen L.Z., HogenEsch H., Park K., and Bowersock T.L. Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine. J. Control Release 85 (2002) 227-235
33. Tafaghodi M., Sajadi Tabassi S.A., and Jaafari M.R. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN. Int. J. Pharm. 319 (2006) 37-43
34. Testi R., D'Ambrosio D., De Maria R., and Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15 (1994) 479-483
35. Ueno H., Mori T., and Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 52 (2001) 105-115
36. van der Lubben I.M., Kersten G., Fretz M.M., Beuvery C., Coos Verhoef J., and Junginger H.E. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 21 (2003) 1400-1408
37. van der Lubben I.M., Verhoef J.C., Borchard G., and Junginger H.E. Chitosan for mucosal vaccination. Adv. Drug Deliv. Rev. 52 (2001) 139-144
38. Wang Y., and Krieg A.M. Synergy between CpG- or non-CpG DNA and specific antigen for B cell activation. Int. Immunol. 15 (2003) 223-231
39. Xu W., Shen Y., Jiang Z., Wang Y., Chu Y., and Xiong S. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Vaccine 22 (2004) 3603-3612